For many years, pharmaceutical therapies for osteoarthritis (OA) have been focused on the degenerating cartilage. However, there is increasing evidence that bone plays an important role in OA as well. The structural and material properties of the subchondral bone are modified, and bone cysts and osteophytes may develop. The mechanisms behind these bone changes are subject of debate, and a better understanding may help in the development of bone-targeting OA therapies.
- Bioengineering Division
Progressive Subchondral Sclerosis During OA Explained by Depth-Dependent Bone Demineralization
- Views Icon Views
- Share Icon Share
- Search Site
Cox, LGE, van Rietbergen, B, van Donkelaar, CC, & Ito, K. "Progressive Subchondral Sclerosis During OA Explained by Depth-Dependent Bone Demineralization." Proceedings of the ASME 2011 Summer Bioengineering Conference. ASME 2011 Summer Bioengineering Conference, Parts A and B. Farmington, Pennsylvania, USA. June 22–25, 2011. pp. 307-308. ASME. https://doi.org/10.1115/SBC2011-53473
Download citation file: